URINARY TRACT INFECTION THERAPEUTIC MARKET ANALYSIS

Urinary Tract Infection Therapeutic Market, By Drug (Penicillin and Combinations, Quinolones, Cephalosporin, Azoles and Amphotericin B, Nitrofurans, and Other Drugs), By Indication (Complicated UTI, Uncomplicated UTI, and Other Indications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031

Published In : Mar 2024
Code : CMI1178
Pages :197
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Urinary Tract Infection Therapeutic Market: Key Companies Insights

The global urinary tract infection therapeutic market is highly competitive. This is attributed to the increase in prevalence of urinary tract infection and growing geriatric population, as a result, players in the market are focusing on launching novel products in the market.

Some of the key players in the global urinary tract infection therapeutic market are Pfizer, Novartis AG, Cipla Inc., Bayer AG, AstraZeneca, Shionogi & Co. Ltd., and GlaxoSmithKline PLC, among others.